Glomerular basement membrane anionic sites in Adriamycin nephropathy: Effect of saline loading and nitric oxide modulation

Nephron

Volumn 84, Issue 4, 2000, Pages 354-361

  Shlomit, Hertzan Levy ^a   Fish, Roman ^a   Skutelsky, Ehud ^a   Wollman, Yoram ^a   Chernichovsky, Tamara ^a   Polak Charcon, Sylvie ^b   Schwartz, Doron ^a   Blum, Miriam ^a   Cabili, Shaltiel ^a   Iaina, Adrian ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Adriamycin nephropathy; Cationic colloidal gold; GBM anionic sites; GBM width; L arginine; Nitric oxide; NOSi; Saline loading

Indexed keywords

ARGININE; COLLOIDAL GOLD; CREATININE; DOXORUBICIN; HEPARAN SULFATE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; KIDNEY DISEASE; KIDNEY FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANIONS; ARGININE; BASEMENT MEMBRANE; BINDING SITES; DOXORUBICIN; ENZYME INHIBITORS; FEMALE; GOLD COLLOID; HEPARAN SULFATE PROTEOGLYCANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRITES; NITROARGININE; RATS; RATS, WISTAR; SODIUM CHLORIDE;

EID: 0034069637     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kanwar YS, Farquhar MG: Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cat-ionic probes. J Cell Biol 1979;81:137-153.
2. Farquhar MG: Glomerular basement membrane. A selective macromolecular filter; in Hay ED (ed): Cell Biology of the Extracellular Matrix. New York, Plenum Press, 1991. pp 367-418.
3. Sawada H, Stukenbrok H, Kerjaschki D, Farquhar MG: Epithelial polyanion (podocalyxin) is found on the sides but not the soles of the foot processes of the glomerular epithelium. Am J Pathol 1986;125:309-318.
4. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI: Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1986;11:390-413.
5. Rennke HG, Cotran RS, Venkatachalam MA: Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol 1975;67:638-646.
6. Kanwar YS, Farquhar MG: Presence of heparan sulfate in glomerular basement membrane. Proc Natl Acad Sci USA 1979;76:1303-1307.
7. Cotran RS, Rennke HG: Anionic sites and the mechanisms of proteinuria. N Engl J Med 1983;309:1050-1052.
8. Brenner BM, Hostetter TH, Humes HD: Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978;298:826-833.
9. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22: 736-744.
10. Myers BD, Winetz JA, Chui F, Michaels AS: Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int 1982;21:633-641.
11. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M: Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 1988;33:100-106.
12. Rohrbach R: Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane. Virchows Arch B 1986;51:127-135.
13. Varnier RL, Steffes MW, Sisson-Ross S, Mauer SM: Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 1992;41:1070-1080.
14. Olson JL, Rennke HG, Venkatachalam MA: Alteration in the charge and size selectivity barrier of the glomerular filter in the aminonucleoside nephrosis. Am J Pathol 1985;118:343-349.
15. Kerjaschki D, Vernillo AT, Farquhar MG: Reduced sialylation of podocalyxin - the major sialoprotein of the rat kidney glomerulus in aminonucleoside nephrosis. Am J Pathol 1985; 118:343-349.
16. Caulfield JP, Farquhar MG: Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis. Lab Invest 1978;39:505-512.
17. Mahan JD, Sisson-Ross S, Varnier RL: Glomerular basement membrane anionic charge site changes early in aminonucleoside nephrosis. Am J Pathol 1986;125:393-401.
18. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua V, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events. Lab Invest 1982;46:16-23.
19. Weening JJ, Rennke HG: Glomerular permeability and polyanion in Adriamycin nephrosis in the rat. Kidney Int 1983;24:152-159.
20. Skutelsky E, Hertzan S, Socher R, Gafter U: Modifications in glomerular polyanion distribution in Adriamycin nephrosis. J Am Soc Nephrol 1995;5:1799-1805.
21. Charest PM, Roth J: Localization of sialic acid in kidney glomeruli: Regionalization in the podocyte plasma membrane and loss in experimental nephrosis. Proc Natl Acad Sci USA 1985;82:8505-8512.
22. Carrie BJ, Salyer WR, Myers BD: Minimal change nephropathy: An electro-chemical disorder of the glomerular membrane. Am J Med 1981;70:262-268.
23. Bridges CR, Myers BD, Brenner BM, Deen WM: Glomerular charge alterations in human minimal change nephropathy. Kidney Int 1982;22:677-684.
24. Hertzan-Levy S, Iaina A, Wollman Y, Chernihovsky T, Yagil C, Yagil Y, Peer G, Skutelsky E: Glomerular basement membrane polyanionic sites and nitric oxide in genetically salt sensitive and resistant hypertension rats. Kidney Blood Press Res 1997;20:218-224.
25. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991;21:361-374.
26. Moncada S, Radomski MW, Palmer RM: Endothelium-derived relaxing factor: Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988;37:2495-2501.
27. Schultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990; 258:F162-F167.
28. Tolins JP, Palmer RM, Moncada S, Raij L: Role of endothelium-derived relaxing factor in regulation of renal hemodynamics responses. Am J Physiol 1990;258:H655-H662.
29. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwanz D, Cabili S, Silverberg D, Iaina A: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-1521.
30. Maree A, Peer G, Iaina A, Blum M, Wollman Y, Chernihovsky T, Silverberg DS, Cabili S: Nitric oxide in streptozotocin-induccd diabetes mellitus in rats. Clin Sci 1996;90:379-384.
31. Reyes AA, Purkerson ML, Karl I, Klahs S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
32. Skutelsky E, Roth J: Cationic colloidal gold - A new probe for the detection of cell surface sites by electron microscopy. J Histochem Cytochem 1986;34:693-696.
33. Goode NP, Shires M, Crellin DM, Davison AM: Detection of glomerular anionic sites in post-embedded ultra-thin sections using cationic colloidal gold. J Histochem Cytochem 1991;39:965-972.
34. Skutelsky E, Shoichetman T, Hammel I: A histochemical approach to characterization of anionic constituents in mast cells secretory granules. Histochem Cell Biol 1995;104:453-458.
35. Weinstein T, Gafter U, Chagnac A, Skutelsky E: Distribution of glycosaminoglycans in rat renal tubular epithelium. J Am Soc Nephrol 1997;8:586-595.
36. Goode NP, Shires M, Aparicio SR, Davidson AM: Cationic colloidal gold - A novel marker for the demonstration of glomerular polyanion status in routine renal biopsies. Nephrol Dial Transplant 1991;6:923-930.
37. Steffes MW, Barbosa J, Basgen JM, Sutherland DER, Najarian JS, Mauer SM: Quantitative glomerular morphology of the normal human kidney. Lab Invest 1983;49:82-86.
38. Jensen EB, Gundersen HJG, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 1979; 115:19-33.
39. Tiebosch ATMG, Frederik PM, Van Breda Vricsman PJC, Mooy JMV, Van Rie H, Van de Wiel TWM, Wolters J, Zeppenfeldt E: Thin-basement-membrane nephropathy in adults with persistent hemaluria. N Engl J Med 1989; 320:8-14.
40. Naicker T, Randeree IGH, Moodley J, Khedun SM, Ramsaroop R, Seedat YK: Correlation between histological changes and loss of anionic charge of the glomerular basement membrane in early-onset pre-eclampsia. Nephron 1997;75:201-207.
41. Chen A, Shev LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron 1998;78:440-452.
42. Klahr S: Can L-arginine manipulation reduce renal diseases? Semin Nephrol 1999;19:304-309.
43. Aiello S, Remuzzi G, Noris M: Nitric oxide/ endothelin balance after nephron reduction. Kidney Int Suppl 1998;65:563-567.
44. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskope I, Kaplan E, Silverberg D, Cabili S, Iaina A: Low nitric oxide production in patients with chronic renal failure. Nephron 1998;79:265-268.
45. Shultz PJ, Tolins JP: Adaptation to increase dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin invest 1993;91:643-650.
46. Podjarny E, Ben-Chetrit S, Rathaus M, Korzets Z, Green J, Katz J, Katz B, Berneim J: Pregnancy-induced hypertension in rats with Adriamycin nephropathy is associated with inadequate production of nitric oxide. Hypertension 1997;29:186-191.
47. Braam B: Renal endothelial and macula densa NOS: Integrated response to changes in extracellular fluid volume. Am J Physiol 1999;276: R1551-R1561.